Where to Buy Soma (Carisoprodol) : Licensed Options
- What Soma (carisoprodol) is and how it is classified
- How it works in the body
- FDA-approved uses and controlled substance schedule
- Dosage forms, strengths, and typical dosing
- Common and serious side effects
- Drug interactions and contraindications
- Precautions, abuse potential, and when to contact a clinician
- Personalized medical advice or treatment recommendations
- Specific dosing for your individual condition
- Information about purchasing medications
- Alternatives to prescribed treatments (consult your provider)
Page Contents
What Is Soma (Carisoprodol)?
Soma is the brand name for carisoprodol, a centrally acting muscle relaxant used for the short-term relief of acute musculoskeletal pain. It is designated as a Schedule IV controlled substance under the federal Controlled Substances Act.
A critical concern with Soma is that it is metabolized in the liver to meprobamate, a substance with known anxiolytic and sedative properties that was formerly a widely prescribed medication with significant abuse potential. This metabolite contributes to Soma's own potential for abuse, misuse, and dependence.
Due to its abuse potential and the lack of evidence supporting efficacy beyond 2–3 weeks, Soma is recommended for short-term use only (typically 2 to 3 weeks).
How Soma (Carisoprodol) Works
Soma (carisoprodol) works primarily by acting on the central nervous system (brain and spinal cord) rather than directly on skeletal muscle. Its exact mechanism of action is not fully understood.
Carisoprodol is thought to block pain sensations between the brain and skeletal muscles via its action in the reticular formation and spinal cord. It has sedative, anxiolytic, and muscle relaxant properties.
An important pharmacological note: carisoprodol is metabolized by CYP2C19 to meprobamate, a barbiturate-like compound. Meprobamate has a long history of abuse and was formerly marketed as a standalone anxiolytic (Miltown/Equanil). The accumulation of meprobamate contributes to Soma's potential for dependence and withdrawal.
FDA Schedule & Classification
| Drug Name | Soma (carisoprodol) |
|---|---|
| Drug Class | Muscle Relaxant (centrally acting) |
| DEA Schedule | Schedule IV (C-IV) |
| Controlled Substance Act | Schedule IV due to potential for abuse, misuse, and dependence |
| Prescription Required | Yes |
| FDA Approval | 1959 |
| Availability | Generic (carisoprodol) and brand-name (Soma) |
FDA-Approved Uses
Soma is FDA-approved for:
- Relief of discomfort associated with acute, painful musculoskeletal conditions — intended as an adjunct to rest, physical therapy, and other measures.
Soma is intended for short-term use only, typically 2 to 3 weeks. There is no evidence of efficacy for long-term use.
Soma is NOT effective for chronic musculoskeletal pain, fibromyalgia, or rheumatologic conditions.
Dosage Forms & Strengths
Oral Tablets
| Strength | Typical Dose (Adults) |
|---|---|
| 250 mg | 250 mg to 350 mg, three times daily and at bedtime |
| 350 mg | 350 mg, three times daily and at bedtime |
The usual adult dose is 250 mg to 350 mg three times daily and at bedtime. Treatment duration should not exceed 2 to 3 weeks.
Elderly patients and those with hepatic impairment may require lower doses.
Side Effects
Common Side Effects
- Drowsiness or sedation — very common; avoid driving or operating machinery
- Dizziness
- Headache
- Upset stomach
- Vomiting
Serious Side Effects
- Severe allergic reaction — hives, difficulty breathing, swelling of face/throat
- Respiratory depression — especially when combined with opioids, benzodiazepines, or alcohol
- Seizures — particularly at high doses or in patients with seizure history
- Abuse, misuse, and dependence — due to metabolism to meprobamate
- Withdrawal symptoms — insomnia, vomiting, abdominal cramps, headache, tremors, muscle twitching, anxiety, psychosis, and potentially seizures
- Severe skin reactions — rare cases of Stevens-Johnson syndrome
Drug Interactions
Carisoprodol is metabolized primarily by CYP2C19 in the liver to the active metabolite meprobamate.
Major Interactions (Avoid or Use Extreme Caution)
- Opioids — concurrent use can cause profound sedation, respiratory depression, coma, and death
- Benzodiazepines — additive CNS depression and respiratory depression
- Alcohol — significantly increases sedation and respiratory depression risk
- Tricyclic antidepressants — additive sedation and anticholinergic effects
Moderate Interactions (Monitor Closely)
- CYP2C19 inhibitors (fluconazole, fluvoxamine) — may increase carisoprodol levels
- Other CNS depressants (antihistamines, sleep aids) — additive sedation
Dependence & Withdrawal
Due to its metabolism to meprobamate, Soma carries a significant risk of physical and psychological dependence. Withdrawal after prolonged use can be life-threatening and may include seizures. Tapering is recommended when discontinuing after extended use.
Precautions & Warnings
- Pregnancy: No adequate studies in pregnant women. Use only if the potential benefit justifies the potential risk.
- Breastfeeding: Carisoprodol is excreted in breast milk. Breastfeeding is generally not recommended.
- Elderly patients: Increased sensitivity to sedation and dizziness. Start at lower doses.
- Liver disease: Patients with hepatic impairment may accumulate carisoprodol and require dose reduction.
- History of substance use disorder: Significantly increased risk of misuse and dependence. Use with extreme caution.
- Seizure history: Soma may lower seizure threshold.
- Driving and machinery: Soma causes significant drowsiness. Do not drive or operate heavy machinery.
When to Contact a Clinician
- Symptoms are not improving after 2–3 weeks of treatment
- You notice new or unexpected side effects
- You feel you need to take more medication to achieve the same effect (tolerance)
- You are having difficulty functioning at work or home due to sedation
- You are experiencing mood changes, depression, or thoughts of self-harm
- You are pregnant or planning to become pregnant
- You want to stop the medication — taper under medical guidance if used for extended periods
Seek emergency care immediately if you experience seizures, difficulty breathing, severe allergic reaction, or loss of consciousness.